1 week Ago By Defense World Staff
DarioHealth Corp. ( NASDAQ:DRIO – Get Free Report ) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 2,010,000 shares, an increase of 5.
2% from the November 30th total of 1,910,000 shares. Based on an average trading volume of 106,600 shares, the days-to-cover ratio is currently 18.9 days.
Institutional Trading of DarioHealth Institutional investors have recently bought and sold shares of the business. XTX Topco Ltd lifted its position in shares of DarioHealth by 81.4% during the 3rd quarter.
XTX Topco Ltd now owns 29,455 shares of the company’s stock valued at $33,000 after buying an additional 13,219 shares in the last quarter. DLK Investment Management LLC raised its position in DarioHealth by 71.6% during the third quarter.
DLK Investment Management LLC now owns 100,550 shares of the company’s stock worth $113,000 after acquiring an additional 41,943 shares during the period. Finally, Appian Way Asset Management LP lifted its holdings in DarioHealth by 2.5% during the third quarter.
Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock valued at $1,580,000 after purchasing an additional 34,990 shares in the last quarter. 33.39% of the stock is owned by institutional investors and hedge funds.
DarioHealth Price Performance NASDAQ:DRIO opened at $0.82 on Friday. The stock has a market capitalization of $27.
99 million, a PE ratio of -0.87 and a beta of 1.47.
DarioHealth has a 52 week low of $0.63 and a 52 week high of $2.60.
The company has a quick ratio of 1.32, a current ratio of 1.57 and a debt-to-equity ratio of 0.
35. The stock’s 50-day moving average price is $0.80 and its 200-day moving average price is $0.
95. DarioHealth Company Profile DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand.
Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. See Also Five stocks we like better than DarioHealth What Investors Need to Know About Upcoming IPOs 3 Legacy Tech Companies Reemerging as AI Leaders Roth IRA Calculator: Calculate Your Potential Returns Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks Insider Selling Explained: Can it Inform Your Investing Choices? Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter .
.
